Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): A randomised, placebo controlled trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 12, 1997, Pages 1391-1397

  McDonald, H M ^a   O'Loughlin J A ^a   Vigneswaran, R ^a   Jolley, P T ^a   Harvey, J A ^b   Bof, A ^c   McDonald, P J ^d  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c LYELL MCEWIN HOSPITAL   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; PLACEBO;

ANTIBIOTIC THERAPY; ARTICLE; BIRTH; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; GARDNERELLA VAGINALIS; HUMAN; LABOR; MAJOR CLINICAL STUDY; NEWBORN; ORAL DRUG ADMINISTRATION; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VAGINITIS;

ADULT; ANTITRICHOMONAL AGENTS; FEMALE; GARDNERELLA VAGINALIS; HUMANS; METRONIDAZOLE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RISK FACTORS; TREATMENT OUTCOME; VAGINOSIS, BACTERIAL;

EID: 0030724880     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11009.x     Document Type: Article

References (28)

1. Regan JA, Chao S, James LS. Premature rupture of membranes, preterm delivery and group B streptococcal colonisation of mothers. Am J Obstet Gynecol 1981; 141: 184–186.
2. Graven MG, Hummell D, Eschenbach DA, Holmes K.K. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986; 67: 229–237.
3. Divers MJ, Lilford RJ. Infection and preterm labor: a meta-analysis. Contemp Rev Obstet Gynaecol 1993; 5: 71–84.
4. Romero R, Mazor J. Infection and pretenn labour. Clin Obstet Gvnecol 1988; 31: 553–584.
5. McGregor JA, French JI, Reller LB, Todd JK, Makowski EL. Adjunctive erythromycin treatment for idiopathic preterm labour: Results of a randomised, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1986; 154: 98–103.
6. Morales WJ, Angel JL, O’Brien WF, Knuppel RA, Finazzo M. A randomised study of antibiotic therapy in idiopathic pretenn labour. Obstet Gynecol 1988; 72: 829–833.
7. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Metanalysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birthweight. Obstet Gynecol 1989; 73: 576–582.
8. McCormack WM, Rosner B, Lee Y-H, Munoz A, Charles D, Kass EH. Effect on birthweight of erythromycin treatment of pregnant women. Obstet Gynecol 1989; 69: 202–207.
9. Eschenbach DA, Nugent RP, Rao AV et al. A randomised placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. Am J Obstet Gynecol 1991; 164: 734–742.
10. Ryan GM, Abdulla TN, McNeely SG, Beselski VS, Drummond DG. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol 1990; 162: 34–39.
11. Thomsen AC, Morup L, Hansen KB. Antibiotic elimination of group B streptococci in urine in prevention of preterm labour. Lancet 1987; 1: 591–593.
12. Fischbach F, Kolben M, Thurmayr R et al. Genitale Infektionen und Schwangerschaftsverlauf: eine prospektive Studie [in German]. GeburtsMfe Frauenheilkd 1988; 48: 469–478.
13. McGregor JA, French JI, Richter R et al. Antenatal microbiological maternal risk factors associated with prematurity. Am J Obstet Gynecol 1990; 163: 1465–1473.
14. Kurki T, Sivonen A, Renkonen O-V, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gvnecol 1992; 80: 173–177.
15. Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial vaginosis and prematurity in Indonesia: Association in early and late pregnancy. Am J Obstet Gynecol 1993; 169: 175–178.
16. Hay PE, Lament RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent pretenn delivery and late miscarriage. BMJ 1994; 308: 295–298.
17. Hillier SL, Nugent RP, Eschenbach DA et al. Association between bacterial vaginosis and pretenn delivery of a low-birth-weight infant. N Engl J Med 1995; 333: 1737–1742.
18. McDonald HM, O’Loughlin JA, Jolley P, Vigneswaran R, McDonald PJ. Prenatal microbiological risk factors associated with preterm birth. Br J Obstet Gynaecol 1992; 99: 190–196.
19. Burtin P, Taddio A, Ariburnu O, Einarson TR, Keren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gvnecol 1995; 172: 525–529.
20. McDonald HM, O’Loughlin JA, Vigneswaran R, Jolley PT, McDonald PJ. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: A randomized controlled trial. Obstet Gynecol 1994; 84: 343–348.
21. McDonald HM, O’Loughlin JA, Jolley P, Vigneswaran R, McDonald PJ. Vaginal infection and preterm labour. Br J Obstet Gynaecol 1991; 98: 427–435.
22. Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis. J Clin Microbiol 1983; 18: 170–177.
23. Rotheram EB, Schick NF. Nonclostridial anaerobic bacteria in non-specific vaginitis. N Engl J Med 1969; 46: 80–89.
24. Joesoef MR, Hillier SL, Wiknjosastro G et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995; 173: 1527–1531.
25. McGregor JA, French JL, Parker R et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gvnecol 1995; 173: 157–167.
26. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with pretenn birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gvnecol 1994; 171: 345–349.
27. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732–1736.
28. Platz-Christiansen JJ, Mattsby-Baltzer I, Thomsen P, Wiqvist N. Endotoxin and interleukin-1α in the cervical mucus and vaginal fluid of pregnant women with bacterial vaginosis. Am J Obstet Gynecol 1993; 169: 1161–1166.